Skip to Content
Merck
CN

Key Documents

View All Documentation

415286

Copper(II) 5,9,14,18,23,27,32,36-octabutoxy-2,3-naphthalocyanine

Dye content 90 %

Synonym(s):

5,9,14,18,23,27,32,36-Octabutoxy-2,3-naphthalocyanine copper(II) salt

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C80H88CuN8O8
CAS Number:
155773-67-4
Molecular Weight:
1353.15
NACRES:
NA.23
PubChem Substance ID:
24865987
UNSPSC Code:
12352103
MDL number:
MFCD00191950
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

powder

composition

Dye content, 90%

λmax

853 nm

SMILES string

CCCCOc1c2ccccc2c(OCCCC)c3c4nc(nc5n6[Cu]n7c(n4)c8c(OCCCC)c9ccccc9c(OCCCC)c8c7nc%10nc(nc6c%11c(OCCCC)c%12ccccc%12c(OCCCC)c5%11)c%13c(OCCCC)c%14ccccc%14c(OCCCC)c%10%13)c13

InChI

1S/C80H88N8O8.Cu/c1-9-17-41-89-65-49-33-25-26-34-50(49)66(90-42-18-10-2)58-57(65)73-81-74(58)86-76-61-62(70(94-46-22-14-6)54-38-30-29-37-53(54)69(61)93-45-21-13-5)78(83-76)88-80-64-63(71(95-47-23-15-7)55-39-31-32-40-56(55)72(64)96-48-24-16-8)79(84-80)87-77-60-59(75(82-77)85-73)67(91-43-19-11-3)51-35-27-28-36-52(51)68(60)92-44-20-12-4;/h25-40H,9-24,41-48H2,1-8H3;/q-2;+2

InChI key

JJIWQZDKAOMTKU-UHFFFAOYSA-N

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBF7673
MKBF7673V
MKBC7798
18396KJ
07006KF

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mattias N D Svensson et al.
Science advances, 6(26), eaba4353-eaba4353 (2020-07-09)
Fibroblast-like synoviocytes (FLS) are joint-lining cells that promote rheumatoid arthritis (RA) pathology. Current disease-modifying antirheumatic agents (DMARDs) operate through systemic immunosuppression. FLS-targeted approaches could potentially be combined with DMARDs to improve control of RA without increasing immunosuppression. Here, we assessed

Global Trade Item Number

SKUGTIN
S3567-5MG04061832449692
S3567-25MG04061832449685
415286-100MG04061833279977